Disclosures for "RGX-202, an Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy: Interim Clinical Data "
-
Dr. Veerapandiyan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AMO Pharma, AveXis, Biogen, Edgewise Therapeutics, FibroGen, Novartis, Pfizer, PTC Therapeutics, Sarepta Therapeutics, Inc., UCB Pharma, Catalyst, Entrada, Scholar Rock, Catalyst, Lupin. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Veerapandiyan has received research support from AMO Pharma, Capricor Therapeutics, Edgewise Therapeutics, FibroGen, Muscular Dystrophy Association, Novartis, Parent Project Muscular Dystrophy, Pfizer, RegenxBio and Sarepta Therapeutics. Dr. Veerapandiyan has received personal compensation in the range of $5,000-$9,999 for serving as a MD with PPMD, MDA.
-
-
Dr. Dastgir has received personal compensation for serving as an employee of Regenxbio.
-
Paulo Falabella has received personal compensation for serving as an employee of REGENXBIO Inc.
-
-
Dr. Rastogi has received personal compensation for serving as an employee of REGENXBIO. Dr. Rastogi has stock in REGENXBIO.
-
Dawn Phillips has received personal compensation for serving as an employee of Regenxbio.
-
Mrs. Wilson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Regenxbio. Mrs. Wilson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Sanofi.
-
Dr. Boulos has received personal compensation for serving as an employee of REGENXBIO. Dr. Boulos has stock in REGENXBIO.
-
Michelle Gilmor has received personal compensation for serving as an employee of REGENXBIO. Michelle Gilmor has stock in REGENXBIO.
-
Dr. Yang has nothing to disclose.
-
Dr. Patel has stock in Regenxbio Inc.
-
Mr. Fiscella has received personal compensation for serving as an employee of REGENXBIO. Mr. Fiscella has stock in REGENXBIO.
-
Dr. Danos has received personal compensation for serving as an employee of REGENXBIO. Dr. Danos has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Bio. Dr. Danos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Coave Therapeutics. Dr. Danos has stock in REGENXBIO. Dr. Danos has stock in Coave Therapeutics. Dr. Danos has stock in Rocket Therapeutics.